Perceptive Advisors’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-389,962
Closed -$3.78M 103
2022
Q3
$3.78M Sell
389,962
-75,200
-16% -$996K 0.11% 90
2022
Q2
$6.74M Sell
465,162
-28,500
-6% -$486K 0.21% 74
2022
Q1
$12.9M Buy
493,662
+39,658
+9% +$1.13M 0.26% 72
2021
Q4
$18M Sell
454,004
-135,000
-23% -$6.15M 0.28% 72
2021
Q3
$29.5M Buy
589,004
+22,920
+4% +$1.25M 0.43% 58
2021
Q2
$31.4M Buy
566,084
+60,000
+12% +$3.2M 0.41% 55
2021
Q1
$23.7M Buy
506,084
+230,000
+83% +$11.1M 0.3% 72
2020
Q4
$12M Sell
276,084
-15,000
-5% -$553K 0.13% 103
2020
Q3
$10.7M Sell
291,084
-44,698
-13% -$1.52M 0.16% 85
2020
Q2
$9.79M Buy
335,782
+7,084
+2% +$196K 0.16% 81
2020
Q1
$8.38M Buy
328,698
+45,000
+16% +$1.37M 0.22% 65
2019
Q4
$9.84M Buy
283,698
+72,774
+35% +$2.41M 0.2% 66
2019
Q3
$6.67M Buy
+210,924
New +$8.3M 0.18% 67

Other funds holding HCAT